CClinicalTrials.gg
RecruitingNCT06204471Updated Jan 12, 2024

Acceptability of Hip Protector Airbags in Older People

An interventional study of Helite hip protector and Wolk hip protector in Falls Risk, sponsored by Royal College of Surgeons, Ireland. Recruiting at 1 site in Ireland. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-01-12.

Sponsored by Royal College of Surgeons, Ireland · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Pilot study evaluating two different airbag hip protectors to see if community-dwelling older people will wear them and find them comfortable and acceptable.

Read the detailed description

Traditional hip protectors are specialised pads designed to shield the greater trochanter on (fall) impact. They have uncertain benefits in reducing hip fracture risk and have very poor uptake due to discomfort. Recently, airbag technology has allowed radical change in design and wearability of hip protectors. Despite these airbags being commercially available, there is little evidence of their acceptability/wearability, and as with all hip protectors, virtually no research exists in community-dwelling people. A study of traditional hip protectors found that they may reduce fear of falling (FoF) in community dwellers but activity levels or quality of life were not assessed. A non-randomised study is ongoing of hip airbags on fractures in nursing homes, but none in community dwellers. Two Hip Protectors available in Europe are CE marked as personal protective equipment and approved for sale. There is a need to evaluate their acceptability and usefulness before considering larger clinical trials evaluating their efficacy in preventing hip fractures. This study will evaluate the two hip protectors and gain patient feedback in their use.

02

Conditions studied

  • Falls Risk

Keywords

  • Hip protector
  • Airbag
03

In context

Lead sponsor

Royal College of Surgeons, Ireland is the lead sponsor of 93 studies on the registry; 44 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 65 years and older
  • 1 or more falls in the last year requiring medical attention
  • Fear of Falling (single question Y/N)
  • Able to give informed consent

Exclusion criteria

Exclusion criteria:

  • Nursing home resident
  • Immobile, or requires another person to assist with transfers and mobility
  • Unable to apply or remove the hip airbag independently
  • Waist circumference \<70cm or >125cm (Helite device is sized by waist) and
  • Hip circumference \<84cm or >125cm (Wolk device sized by hip)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Airbag1

    Airbag1 worn for two months

    Device: Helite hip protector · Device: Wolk hip protector

  • Experimental
    Airbag2

    Airbag2 worn for 2 months

    Device: Helite hip protector · Device: Wolk hip protector

Interventions

  • DeviceHelite hip protector

    hip protector

  • DeviceWolk hip protector

    Hip protectdor

06

What researchers measure

Primary outcomes

  1. Acceptability and useability of a hip protector airbag, qualitative analysis

    Tolerance of, and psychosocial impact of wearing a hip protector airbag will be explored through a semi-structured in-depth interview at the end of each 2-month period of wearing the airbag. This will explore significant patterns and themes related to acceptability of each airbag through deductive interview content analysis.

    Time frame: After 2 month period of wearing each airbag

Secondary outcomes

  1. Acceptability and useability of a hip protector airbag, quantitative measure

    SUS (System Usability Scale): The SUS is adapted for the purposes of this study, from similar in the literature and consists of 10 questions each uses a 10 point Likert scale rating factors such as ease of use, charging the device, appearances etc. A high score (100 max score) means highly rated, and 10 (lowest score) means poorly rated.

    Time frame: After 2 months of wearing each device.

  2. Fear of falling (FoF)

    FoF will be assessed using the FES1 (Falls Efficacy Scale International 1) questionnaire. This uses a 4 point scale for subjective level of concern for 16 questions related to falls and activity. Maximum scores is 64 for highest level of concern or fear of falling.

    Time frame: After 2 months of wearing each device

07

Study locations

1 of 1 sites recruiting
  • Beaumont Hospital
    Dublin, Ireland
    • Frances Dockery · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — tbc

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06204471
Lead sponsor
Royal College of Surgeons, Ireland
Collaborators
Beaumont Hospital
Responsible party
Sponsor
First posted
Jan 12, 2024
Start date
Jan 2, 2024
Primary completion
Dec 2024 (estimated)
Completion
Apr 2025 (estimated)
Last update
Jan 12, 2024

Study contacts

Frances Dockery, MD
Contact
francesdockery@beaumont.ie
+35318093000
Frances Dockery, MD
principal investigator · Beaumont Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion